Agencies rock for a good cause at Pharmapalooza

Share this article:
Agencies rock for a good cause at Pharmapalooza
Agencies rock for a good cause at Pharmapalooza

Corbett Accel Healthcare Group can add music to its list of creative achievements after its Chicago office triumphed in last night's Pharmapalooza “battle of the bands” contest at B.B. King's Blues Club & Grill in New York City.

Heavy Medical — comprising Jeff Holtorf (drums), Terry Barich (harmonica, vocals), Brian Catral (keyboards, vocals), Jack Cunningham (bass, vocals), Joe Mason (theremin, vocals), Matt Pearl (guitar, vocals) Nicole Stachura (percussion, vocals) and Kelly Christiansen (percussion, vocals) — rocked a sell-out crowd of 750 vociferous industry colleagues and supporters.

In second place was Late Night Car Service (a.k.a. Sudler & Hennessey) which got the vote from MM&M's unofficial panel in attendance. But the real winners of the charity event, which was conceived and organized by New York-based Cline Davis & Mann, was the Children's Hospital at Montefiore, for whom more than $110,000 was raised.

Other contestants were May Cause Nausea (Ogilvy Healthworld), Grand pRx (GSW Worldwide), Pharmatopia (Corbett Accel New York), Mr. Tiny's Revenge (Grey Healthcare Group), SIDEFX (Regan Campbell Ward • McCann), BANDRx (AgencyRx) and Black Box Warning (Harrison & Star). CDM had set the tone with an impressive opening set from its 21-member ensemble, Uncle Funkus.

 

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.